生物医学工程技术Image production.pptx

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Molecular Imaging Technology for DiagnosticsTypical Imaging TechniquesX-Ray Computed Tomography (X-CT);Magnetic Resonance Imaging (MRI);Positron Emission Tomography (PET);Single-Photon Emission Computed Tomography (SPECT);Optical Imaging (OI);Ultrasound image (US);……Molecular imaging in drug developmentNature Reviews Drug Development, 2008, 7, 591However, how to judge efficiently which one isthe most promising candidate for new drug?The key issues for drug development药物研发的关键问题?The activity, targeting ability and the pharmacokinetics of drug药物的活性,靶向,药物代谢等Indeed, the estimated costs of bringing a new potential drug to the end of Phase IIItrials increased approximately 2.5-fold between 1991 and 2001, from US$318 million to $802 million. Assuming a similar cost growth rate, the costs for a new approved drug in 2013 would be $1.9 billion.Molecular imaging is a key method.Abstract | Molecular imaging can allow the non-invasive assessment of biological and biochemical processes in living subjects. Such technologies therefore have the potential to enhance our understanding of disease and drug activity during preclinical and clinical drug development, which could aid decisions to select candidates that seem most likely to be successful or to halt the development of drugs that seem likely to ultimately fail. Here, with an emphasis on oncology, we review the applications of molecular imaging in drug development, highlighting successes and identifying key challenges that need to be addressed for successful integration of molecular imaging into the drug development process.Molecular imaging in drug developmentNature Reviews Drug Development, 2008, 7, 591药物研发的关键问题?药物的活性,靶向,药物代谢等Indeed, the estimated costs of bringing a new potential drug to the end of Phase III trials increased approximately 2.5-fold between 1991 and 2001, from US$318 million to $802 million. Assuming a similar cost growth rate, the costs for a new approved drug in 2013 would be $1.9 billion.X-

文档评论(0)

autohhh + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档